LYMEU:SW:SW-Lyxor MSCI Europe (DR) UCITS ETF Acc EUR (CHF)

ETF | Others |

Last Closing

USD 173.78

Change

+0.92 (+0.53)%

Market Cap

USD 0.71B

Volume

183.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

+0.09 (+0.66%)

USD 1,244,681.59B
SPISI:SW UBS ETF (CH) - SPI® ESG (CHF)..

+0.03 (+0.22%)

USD 590,186.66B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.02 (+0.10%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

-0.11 (-0.39%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

+468.00 (+4.67%)

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+268.00 (+4.11%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+90.50 (+4.47%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+80.00 (+3.11%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

+0.08 (+0.11%)

USD 131,872.43B

ETFs Containing LYMEU:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.20% 66% D+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.20% 64% D 62% D
Trailing 12 Months  
Capital Gain -1.99% 32% F 35% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.99% 30% F 33% F
Trailing 5 Years  
Capital Gain 52.22% 60% D- 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.22% 57% F 65% D
Average Annual (5 Year Horizon)  
Capital Gain 8.36% 69% C- 70% C-
Dividend Return 8.36% 69% C- 69% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.49% 26% F 33% F
Risk Adjusted Return 62.00% 41% F 47% F
Market Capitalization 0.71B 63% D 59% D-

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.